Notice of Results

About this update from Eden Research Plc

15 September 2025         Eden Research Plc ("Eden" or "Company")   Notice of Results   Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, today confirms that it will announce its interim financial results for the six months ended 30 June 2025 on 17 September 2025 (the "Interim Results").   CEO Sean Smith and CFO Alex Abrey will provide a live presentation relating to the Interim Results via Investor Meet Company on 17 September 2025, 11:00 BST.   The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 16 Sept 2025, 09:00 BST, or at any time during the live presentation.   Investors can sign up to Investor Meet Company for free and add to meet EDEN RESEARCH PLC via:   https://www.investormeetcompany.com/eden-research-plc/register-investor   Investors who already follow EDEN RESEARCH PLC on the Investor Meet Company platform will automatically be invited.     -- ENDS --     For further information contact:   Eden Research plc www.edenresearch.com Sean Smith Alex Abrey     01285 359 555 Cavendish Capital Markets Limited (Nominated advisor and broker) Giles Balleny / George Lawson (Corporate Finance) Harriet Ward (Broking) Michael Johnson (Sales)     020 7397 8900 Oberon Capital (Joint broker) 020 3179 5300 Nick Lovering Mike Seabrook Adam Pollock   Hawthorn Advisors (Financial PR) Victoria Ainsworth   [email protected]       Notes to Editors:   Eden Research  is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.   Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has three products currently on the market:   Based on plant-derived active ingredients,  Mevalone ®   is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops.  It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.   Cedroz ™   is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally.  Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.   Eden's seed treatment product,  Ecovelex ™ was developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops. Ecovelex works by creating an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product is based on Eden's plant-derived chemistry, registered in the EU, U.S. and elsewhere, and formulated using Eden's Sustaine® microencapsulation system.   Eden's  Sustaine ®   encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.   Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange  Green Economy Mark  in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.   For more information about Eden, please visit:   www.edenresearch.com

View stock analysis, news, and events for Eden Research Plc